We helped transform a company with diverse clinical and commercial assets into a focused, specialty pharma.
To achieve this, we:
built a bespoke business model based on analysis of the client’s portfolio and commercial strengths;
identified viable alternative growth scenarios, and evaluated risk and value implications of each;
worked with the Board of Directors to agree a major corporate transformation plan.